National Comprehensive Cancer Network

|
|
|
|
For Patients
About the NCCN Clinical Practice Guidelines in Oncology™
Recent Updates to NCCN Clinical Practice Guidelines in Oncology™
NCCN Categories of Evidence and Consensus
NCCN Guidelines Steering Committee
Submission Request to the NCCN Guidelines Panels
NCCN Guidelines Panels-Meeting Schedule
NCCN Drugs & Biologics Compendium™
About the NCCN Drugs & Biologics Compendium™
Compendium Chapters
No Longer Recommended Uses
JNCCN – The Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements

Clinical Recommendations

NCCN 2nd Annual Congress Hematologic Malignancies

Clinicians

Register Online

Congress Information

Program Overview

Educational Objectives

Conference Agenda

Intended Audience

Accreditation

Accommodations

Commercial Support

Exhibiting

Refer a Friend


Go back to previous page

 

 

     
 

Commercial Support

This Congress is supported by educational grants from Amgen, Bayer HealthCare Pharmaceuticals Inc., Bristol-Myers Squibb Company, Celgene Corporation, Cephalon Oncology, Eisai Inc., Genentech BioOncology, Genzyme Oncology, Merck Oncology, MGI PHARMA, INC., Millenium Pharmaceuticals, Inc., Novartis Oncology, Ortho Biotech, Pharmion Corporation, and sanofi-aventis U.S.

No personal information is provided to any grant providers.